Correction to: International Journal of Legal Medicine (2018) 132:1645–1657
The following clarification to the content of Table 3 (MDMB-CHMICA data from previously published cases of acute (non-fatal) and fatal drug intoxications) of the named manuscript needs to be brought to the readership’s attention:
The last two cases cited from the Seywright et al. (2016) publication need to be considered as autopsy cases (not a fatal intoxication as stated for case 44/m) and should read as follows:
Autopsy cases | 44/m | Post-mortem blood | 1 ng/mL |
38/m | < 1 ng/mL |
References
Seywright A, Torrance HJ, Wylie FM, McKeown DA, Lowe DJ, Stevenson R (2016) Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA. Clin Toxicol 54 (8):632–637. https://doi.org/10.1080/15563650.2016.1186805
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s00414-018-1911-8
Rights and permissions
About this article
Cite this article
Gaunitz, F., Lehmann, S., Thomas, A. et al. Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. Int J Legal Med 133, 973 (2019). https://doi.org/10.1007/s00414-018-1976-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-018-1976-4